 |
|
Impact of Vascular Endothelial Growth Factor on Skin Graft Survival in Irradiated Rats
Gresham T. Richter, MD;
Travis Bowen III, MS;
Marjan Boerma, PhD;
Chun-Yang Fan, MD, PhD;
Martin Hauer-Jensen, MD, PhD;
Emre Vural, MD
Arch Facial Plast Surg. 2009;11(2):110-113.
Objective To evaluate the effect of vascular endothelial growth factor (VEGF) on full-thickness skin graft (FTSG) survival on irradiated tissue as a model of wound healing in ischemic conditions.
Design Twenty-four Sprague-Dawley rats underwent 30 Gy of irradiation to their left dorsum (10 Gy/d). After 4 weeks of recovery, 3-cm FTSGs were harvested from the healthy contralateral dorsum and placed onto irradiated recipient beds. Before grafting, recipient beds were delivered subfascial injections of either VEGF protein (5 µg) or physiologic saline. Graft failure (more than 10% necrosis) and graft microvascular density were compared between groups.
Results Seven of the 11 FTSGs from saline-treated irradiated beds (64%) failed, whereas the failure rate for grafts treated with VEGF was 23% (3 of 13) (P = .048). Mean microvascular density was not different between groups.
Conclusion Exogenously administered VEGF may improve the outcome of FTSGs on irradiated tissue beds.
Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery (Drs Richter and Vural and Mr Bowen) and Surgery (Drs Boerma and Hauer-Jensen), University of Arkansas for Medical Sciences, Little Rock; and Departments of Surgery (Drs Boerma and Hauer-Jensen) and Pathology (Dr Fan) and Division of Otolaryngology–Head and Neck Surgery (Dr Vural), John McClellan Veterans Affairs Hospital, Central Arkansas Veterans Healthcare System, Little Rock. Dr Richter is now with the Department of Pediatric Otolaryngology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
|
